CompletedPhase 3NCT02011958
Efficacy Trial of Ambisome Given Alone and Ambisome Given in Combination With Miltefosine for the Treatment of VL HIV Positive Ethiopian Patients.
Studying Leishmaniasis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Drugs for Neglected Diseases
- Principal Investigator
- Ermias Diro, Dr. MDUniversity of Gondar
- Intervention
- Liposomal Amphotericin B(drug)
- Enrollment
- 59 target
- Eligibility
- 18-60 years · All sexes
- Timeline
- 2014 – 2017
Study locations (2)
- MSF, Abdurafi, Ethiopia
- Leishmaniasis Research Center, University Hospital of Gondar, Gonder, Ethiopia
Collaborators
Medecins Sans Frontieres, Netherlands · London School of Hygiene and Tropical Medicine · Addis Ababa University · Institute of Tropical Medicine, Belgium · Slotervaart Hospital · University of Gondar
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02011958 on ClinicalTrials.govOther trials for Leishmaniasis
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT07487350Recurrent Visceral Leishmaniasis in HIV Co-InfectionInstitute of Tropical Medicine, Belgium
- ACTIVE NOT RECRUITINGNANCT06983665Human Bioequivalence Study of Liposomal Amphotericin B for InjectionSichuan Huiyu Pharmaceutical Co., Ltd
- RECRUITINGPHASE2NCT06798415Intralesional Injection of Metronidazole for the Management of Cutaneous LeishmaniasisHayder Adnan Fawzi
- RECRUITINGPHASE2NCT06797544Intralesional Injection of Levofloxacin for the Management of Cutaneous LeishmaniasisHayder Adnan Fawzi
- RECRUITINGPHASE2NCT06798402Ciprofloxacin Intralesional Injection for the Treatment of Cutaneous Leishmaniasis Compared to Sodium StibogluconateAl-Mustafa University College
- RECRUITINGPHASE2NCT06550609Treatment of Bolivian L Braziliensis Mucosal Leishmaniasis with Inhaled Pentamidine Plus Oral MiltefosineFundacion Nacional de Dermatologia
- RECRUITINGNCT06514560OPTImizing MIltefosine Treatment for Cutaneous LEISHmaniasis PatientsInstitute of Tropical Medicine, Belgium
- RECRUITINGNANCT06307171Human Leishmaniasis: Antigen Recognition Pattern and Study of New Potential BiomarkersIRCCS Sacro Cuore Don Calabria di Negrar